A detailed history of Rothschild Investment LLC transactions in 89bio, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 110 shares of ETNB stock, worth $1,043. This represents 0.0% of its overall portfolio holdings.

Number of Shares
110
Previous 45 144.44%
Holding current value
$1,043
Previous $360,000 126.11%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$7.36 - $9.66 $478 - $627
65 Added 144.44%
110 $814,000
Q2 2024

Jul 30, 2024

BUY
$7.31 - $10.9 $328 - $490
45 New
45 $360,000
Q1 2024

Jul 31, 2024

SELL
$8.13 - $13.77 $284 - $481
-35 Reduced 77.78%
10 $116,000

Others Institutions Holding ETNB

About 89bio, Inc.


  • Ticker ETNB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,484,500
  • Market Cap $441M
  • Description
  • 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...
More about ETNB
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.